iShares Nasdaq Biotechnology ETF (IBB)
Description
The investment seeks to track the performance of the ICE Biotechnology Index. The IBB ETF contains 267 constituents. It is focused on growth holdings in the North America region.
Price $117.58 as of 2022-10-20Cost/Risk/Yield
| Dividend yield | 0.3% |
| Expense ratio | 0.45% |
| Average spread | 0.017% |
| 1Y roundtrip cost | 0.467% |
Historic prices
Total Returns (including dividends)
Monthly returns heatmap
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2022 | -13.6% | -4.4% | 3.5% | -10.5% | 0.0% | 0.8% | 5.5% | -2.1% | -3.6% | 0.5% | -23.8% | ||
| 2021 | 6.0% | -2.3% | -4.0% | 2.7% | -1.7% | 7.7% | 1.3% | 3.9% | -6.1% | -1.3% | -3.4% | -1.0% | 1.9% |
| 2020 | -5.6% | 0.1% | -5.3% | 15.1% | 8.7% | 1.5% | -1.7% | 0.9% | -0.1% | -3.5% | 11.0% | 4.5% | 25.6% |
| 2019 | 13.8% | 2.8% | -0.8% | -4.8% | -6.1% | 9.2% | -3.2% | -2.6% | -3.3% | 7.9% | 11.5% | 0.8% | 25.2% |
| 2018 | 6.8% | -5.3% | -1.2% | -2.9% | 4.6% | 1.4% | 6.1% | 4.9% | -0.2% | -14.7% | 4.8% | -11.6% | -7.2% |
| 2017 | 4.8% | 6.9% | -1.2% | 1.5% | -4.0% | 8.6% | 2.9% | 4.5% | 0.1% | -5.8% | 0.5% | 1.6% | 20.2% |
| 2016 | -21.1% | -4.9% | 2.7% | 2.7% | 4.4% | -8.0% | 12.5% | -3.0% | 3.1% | -11.3% | 6.8% | -3.1% | -19.1% |
| 2015 | 6.0% | 4.9% | 1.8% | -2.8% | 9.4% | 1.1% | 3.7% | -10.6% | -11.3% | 7.3% | 2.7% | 1.2% | 13.4% |
| 2014 | 8.3% | 7.5% | -10.6% | -2.6% | 4.1% | 7.4% | -2.4% | 10.3% | -1.0% | 8.4% | 2.5% | -0.2% | 31.6% |
| 2013 | 6.1% | 1.5% | 8.2% | 7.7% | 4.2% | -3.1% | 13.8% | -2.1% | 8.2% | -2.0% | 9.2% | 1.3% | 53.0% |
| 2012 | 11.2% | 2.6% | 3.6% | 1.7% | -1.7% | 5.6% | 3.0% | 1.9% | 4.8% | -7.5% | 5.2% | -1.0% | 29.3% |
| 2011 | 0.3% | 1.0% | 5.8% | 7.3% | 1.8% | -2.5% | -2.6% | -7.4% | -3.0% | 5.2% | 4.0% | 2.1% | 12.1% |
| 23.1% | 10.5% | 2.3% | 15.1% | 23.6% | 30.0% | 38.8% | -1.3% | -12.3% | -16.8% | 54.8% | -5.5% |
Historical Dividends
Monthly dividend heatmap
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2022 | 0.12 | 0.03 | 0.16 | 0.31 | |||||||||
| 2021 | 0.13 | 0.02 | 0.12 | 0.04 | 0.32 | ||||||||
| 2020 | 0.06 | 0.13 | 0.06 | 0.07 | 0.31 | ||||||||
| 2019 | 0.08 | 0.07 | 0.06 | 0.21 | |||||||||
| 2018 | 0.16 | 0.03 | 0.19 | ||||||||||
| 2017 | 0.10 | 0.06 | 0.04 | 0.12 | 0.32 | ||||||||
| 2016 | 0.05 | 0.05 | 0.03 | 0.03 | 0.16 | ||||||||
| 2015 | 0.02 | 0.00 | 0.01 | 0.03 | |||||||||
| 2014 | 0.13 | 0.02 | 0.15 | ||||||||||
| 2013 | 0.02 | 0.02 | |||||||||||
| 2012 | 0.01 | 0.06 | 0.11 | 0.03 | 0.22 | ||||||||
| 2011 | 0.00 | 0.00 | |||||||||||
| 0.00 | 0.00 | 0.46 | 0.00 | 0.00 | 0.77 | 0.00 | 0.00 | 0.65 | 0.00 | 0.00 | 0.37 |
Sectors and Top Holdings
| Security | % Assets |
|---|---|
| Moderna, Inc. | 7.96% |
| Amgen Inc. | 7.92% |
| Gilead Sciences, Inc. | 6.64% |
| Regeneron Pharmaceuticals, Inc. | 5.03% |
| Illumina, Inc. | 3.90% |
| IQVIA Holdings Inc | 3.84% |
| BioNTech SE Sponsored ADR | 3.76% |
| Vertex Pharmaceuticals Incorporated | 3.69% |
| Biogen Inc. | 3.10% |
| Mettler-Toledo International Inc. | 2.65% |
| Seagen, Inc. | 2.52% |
| Waters Corporation | 1.74% |
| Charles River Laboratories International, Inc. | 1.71% |
| Genmab A/S Sponsored ADR | 1.61% |
| Bio-Techne Corporation | 1.56% |
| Top 15 Weights | 57.63% |
Compare with similar ETFs
| IBB | IBBQ | IDNA | IEIH | IXJ | PBE | |
|---|---|---|---|---|---|---|
| Product name | iShares Nasdaq Biotechnology ETF | Invesco Nasdaq Biotechnology ETF | iShares Genomics Immunology and Healthcare ETF | iShares Evolved U.S. Innovative Healthcare ETF | iShares Global Healthcare ETF | PowerShares Dynamic Biotechnology & Genome Portfolio ETF |
| Issuer | iShares | Invesco | iShares | iShares | iShares | Invesco |
| Price | $117.58 | $18.95 | $26.91 | $34.1348 | $76.7 | $59.39 |
| Expense Ratio | 0.45% | 0% |  0.47% |  0.18% | 0.43% | 0.59% |
| Average Spread | 0.017% | 0.211% | 0.223% | 0.146% | 0.117% | 0.253% |
| AUM | $7,490,990,000 | $33,791,400 | $184,587,000 | $40,743,700 | $3,099,990,000 | $226,683,000 |
| Shares | 63,709,707 | 1,783,189 | 6,859,406 | 1,193,612 | 40,417,143 | 3,816,854 |
| Average Daily Volume | 1,968,141 | 8,192 | 54,549 | 2,776 | 205,363 | 8,743 |
| Home page | Visit external site | Visit external site | Visit external site | Visit external site | Visit external site | Visit external site |
| Inception Date | 2001-02-05 | 2021-06-11 | 2019-06-11 | 2018-03-21 | 2001-11-13 | 2005-06-23 |
| Index Tracked | ICE Biotechnology Index | NASDAQ Biotechnology Index | NYSE FactSet Global Genomics and Immuno Biopharma Index | No Underlying Index | S&P Global 1200 Healthcare Sector Index | Dynamic Biotechnology & Genome Intellidex Index |
| Category | Health & Biotech Equities | n/a | Health & Biotech Equities | Health & Biotech Equities | Health & Biotech Equities | Health & Biotech Equities |
| Asset Class | Equity | Equity | Equity | Equity | Equity | Equity |
| Asset Class Size | Large/Mid Caps | Large/Mid Caps | Large/Mid/Small Caps | Large/Mid Caps | Large Caps | Large/Mid/Small Caps |
| Value or Growth | Growth | Blend | Growth | Blend | Growth | |
| Region | North America | North America | North America | North America | North America | North America |
| Countries | U.S. | U.S. | U.S. | U.S. | Broad | U.S. |
| Annual Dividend Rate | $0.349 | $0.224 | $0.392 | $0 | $1.033 | $0 |
| Annual Dividend Yield | 0.003% | 0.012% | 0.015% | 0.000% | 0.013% | 0.000% |
| Number of Holdings | 267 | 268 | 48 | 247 | 115 | 30 |
| YTD Return | -22.76% | -19.61% | -38.29% | -3.74% | -14.53% | -16.60% |
| Beta | 1.25 | 0.95 | 0.93 | 0.88 | 0.87 | 1.22 |
| Upside Beta | 0.31 | -1.23 | 0.15 | 0.55 | 0.25 | 0.12 |
| Downside Beta | 0.31 | -1.22 | -0.26 | 0.59 | 0.17 | 0.09 |
| Volatility 1Y | 28.90% | 28.75% | 37.65% | 18.00% | 17.57% | 30.04% |
| Sharpe Ratio 3Y | 0.20 | 0.00 | 0.12 | 0.95 | 0.69 | 0.31 |
| Treynor Ratio 3Y | 0.00 | 0.00 | 0.00 | 0.01 | 0.01 | 0.00 |